- Previous Close
0.3069 - Open
0.3150 - Bid 0.2189 x 200
- Ask 0.3892 x 200
- Day's Range
0.2968 - 0.3198 - 52 Week Range
0.2400 - 5.0900 - Volume
273,647 - Avg. Volume
1,093,033 - Market Cap (intraday)
8.992M - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-2.8600 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.87
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.
www.relmada.comRecent News: RLMD
View More
Performance Overview: RLMD
Trailing total returns as of 3/27/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RLMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RLMD
View MoreValuation Measures
Market Cap
8.99M
Enterprise Value
-45.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.19
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-69.48%
Return on Equity (ttm)
-116.60%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-86.49M
Diluted EPS (ttm)
-2.8600
Balance Sheet and Cash Flow
Total Cash (mrq)
54.12M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-23.01M
Research Analysis: RLMD
View MoreResearch Reports: RLMD
View MoreDaily – Vickers Top Insider Picks for 12/09/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 12/06/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 12/05/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 12/04/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.